tiprankstipranks
Checkpoint Therapeutics Inc (CKPT)
NASDAQ:CKPT
US Market

Checkpoint Therapeutics (CKPT) Financial Statements

Compare
1,973 Followers

Checkpoint Therapeutics Financial Overview

Checkpoint Therapeutics's market cap is currently $197.77M. The company's EPS TTM is $-1.441; its P/E ratio is ―; Checkpoint Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 103.00K$ 192.00K$ 268.00K$ 1.07M$ 1.71M
Operating Income$ -52.15M$ -58.33M$ -56.72M$ -23.20M$ -24.85M
EBITDA$ -52.15M$ -58.33M$ -56.72M$ -23.20M$ -24.71M
Net Income$ -51.85M$ -62.62M$ -56.67M$ -23.08M$ -24.71M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 5.38M$ 13.29M$ 55.73M$ 42.60M$ 26.97M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.93M$ -12.07M$ -54.73M$ -40.77M$ -26.08M
Total Liabilities$ 18.43M$ 32.77M$ 25.98M$ 7.22M$ 8.12M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -47.59M$ -57.55M$ -26.31M$ -16.55M$ -21.37M
Operating Cash Flow$ -47.59M$ -57.55M$ -26.31M$ -16.55M$ -21.37M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Checkpoint Therapeutics Earnings and Revenue History

Checkpoint Therapeutics Debt to Assets

Checkpoint Therapeutics Cash Flow

Checkpoint Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis